CoChat

Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity

Open access
Wang, Yun, Guo, Lin, Jiang, Hua‐Feng, Zheng, Long‐Tai, Zhang, Ao, Zhen, Xue‐Chu · 2016 · CNS Neuroscience & Therapeutics
Cited by 59

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Summary: Aims: Sigma‐1 receptors are involved in the pathophysiological process of several neuropsychiatric diseases such as epilepsy, depression. Allosteric modulation represents an important mechanism for receptor functional regulation. In this study, we examined antidepressant activity of the latest identified novel and selective allosteric modulator of sigma‐1 receptor 3‐methyl‐phenyl‐2, 3, 4, 5‐tetrahydro‐1H‐benzo[d]azepin‐7‐ol (SOMCL‐668). Methods and Results: A single administration of SOMCL‐668 decreased the immobility time in the forced swimming test (FST) and tailing suspended test in mice, which were abolished by pretreatment of sigma‐1 receptor antagonist BD 1047. In the chronic unpredicted mild stress (CUMS) model, chronic application of SOMCL‐668 rapidly ameliorated anhedonia‐like behavior (within a week), accompanying with the enhanced expression of brain‐derived neurotrophic factor (BDNF) and phosphorylation of glycogen synthase kinase 3 β (GSK 3 β) (Ser‐9) in the hippocampus. SOMCL‐668 also rapidly promoted the phosphorylation of GSK 3 β (Ser‐9) in an allosteric manner in vitro. In the cultured primary neurons, SOMCL‐668 enhanced the sigma‐1 receptor agonist‐induced neurite outgrowth and the secretion of BDNF. Conclusion: SOMCL‐668, a novel allosteric modulator of sigma‐1 receptors, elicits a potent and rapid acting antidepressant effect. The present data provide the first evidence that allosteric modulation of sigma‐1 receptors may represent a new approach for antidepressant drug discovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cns.12502

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 59

Metadata

Authors
Wang, Y., Guo, L., Jiang, H., Zheng, L., Zhang, A., & Zhen, X.
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2016-02-08
Volume
22
Issue
5
Pages
368-377
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W2258397037
Cited by
59
References
8
FWCI
2.56
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity. https://app.cochat.ai/papers/10.1111/cns.12502
The paper
Wang, Y., Guo, L., Jiang, H., Zheng, L., Zhang, A., & Zhen, X. (2016). Allosteric Modulation of Sigma‐1 Receptors Elicits Rapid Antidepressant Activity. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.12502

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.